Craig Leppert grew up with a painful condition that left him in extreme pain when exposed to sunlight. As an adult, he ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

Drugmaker GSK said it agreed to acquire Californian biopharmaceutical company RAPT Therapeutics RAPT-0.02%decrease; red down pointing triangle for around $2.2 billion, a move set to bolster its ...

Please provide your email address to receive an email when new articles are posted on . More children treated with the Viaskin Peanut patch vs. placebo were classified as responders at 12 months. DBV ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

GSK has agreed to buy a pharmaceutical firm that is developing treatment for people with food allergies in a deal valued at 2.2 billion US dollars (£1.6 billion). The London-listed company said the ...

The Microgen enterprise of the Natsimbio holding of Rostec State Corporation has released into civilian circulation a new Russian drug for the treatment of allergies — an allergen from house dust ...

For families living with peanut allergy, daily life is shaped by constant vigilance—reading labels, avoiding social risks, and managing the ever-present fear of accidental exposure. While advances in ...

RICHMOND, VA, UNITED STATES, January 16, 2026 /EINPresswire.com/ — Proactive MD ®, national leader in value-based care, announced the acquisition of allergy ...